Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation.

World journal of hepatology

Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M.
PMID: 25866602
World J Hepatol. 2015 Apr 08;7(4):649-61. doi: 10.4254/wjh.v7.i4.649.

Liver transplantation is the only therapeutic option which allows to treat both, the hepatocellular carcinoma and the underlying liver disease. Indeed, liver transplantation is considered the standard of care for a subset of patients with cirrhosis and hepatocellular carcinoma....

Cite
Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol. 2015;7(4):649-61doi: 10.4254/wjh.v7.i4.649.
Guerrero-Misas, M., Rodríguez-Perálvarez, M., & De la Mata, M. (2015). Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World journal of hepatology, 7(4), 649-61. https://doi.org/10.4254/wjh.v7.i4.649
Guerrero-Misas, Marta, et al. "Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation." World journal of hepatology vol. 7,4 (2015): 649-61. doi: https://doi.org/10.4254/wjh.v7.i4.649
Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol. 2015 Apr 08;7(4):649-61. doi: 10.4254/wjh.v7.i4.649. PMID: 25866602; PMCID: PMC4388993.
Copy Download .nbib Format: NLM
Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme.

Gastroenterologia y hepatologia

Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea Á, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-Perálvarez ML.
PMID: 34400186
Gastroenterol Hepatol. 2021 Aug 14; doi: 10.1016/j.gastrohep.2021.07.010. Epub 2021 Aug 14.

AIM: To determine the prevalence of endoscopic lesions unrelated with portal hypertension in patients with cirrhosis.PATIENTS AND METHODS: Cross-sectional study including a consecutive cohort of patients with liver cirrhosis enrolled in a screening program of oesophageal varices who underwent...

Cite
Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, et al. Hallazgos endoscópicos no relacionados con hipertensión portal en pacientes con cirrosis hepática sometidos a un programa de cribado de varices. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterol Hepatol. 2021;doi: 10.1016/j.gastrohep.2021.07.010.
Santos Lucio, A., Rodríguez Tirado, I., Aparicio Serrano, A., Jurado García, J., Barrera Baena, P., González Galilea, �. �., Poyato González, A., Pleguezuelo Navarro, M., Costán Rodero, G., Casáis Juanena, L., Montero Álvarez, J. L., de la Mata, M., Hervás Molina, A. J., & Rodríguez-Perálvarez, M. L. (2021). Hallazgos endoscópicos no relacionados con hipertensión portal en pacientes con cirrosis hepática sometidos a un programa de cribado de varices. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterologia y hepatologia, . https://doi.org/10.1016/j.gastrohep.2021.07.010
Santos Lucio, Ana, et al. "Hallazgos endoscópicos no relacionados con hipertensión portal en pacientes con cirrosis hepática sometidos a un programa de cribado de varices." Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterologia y hepatologia vol. (2021). doi: https://doi.org/10.1016/j.gastrohep.2021.07.010
Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea Á, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-Perálvarez ML. Hallazgos endoscópicos no relacionados con hipertensión portal en pacientes con cirrosis hepática sometidos a un programa de cribado de varices. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterol Hepatol. 2021 Aug 14; doi: 10.1016/j.gastrohep.2021.07.010. Epub 2021 Aug 14. Spanish. PMID: 34400186.
Copy Download .nbib Format: NLM
Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].

Gastroenterologia y hepatologia

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.
PMID: 29929828
Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011.

No abstract available.

Cite
Aller R, Fernández-Rodríguez C, Lo Iacono O, et al. Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterol Hepatol. 2018;41(7):475-476doi: 10.1016/j.gastrohep.2018.05.011.
Aller, R., Fernández-Rodríguez, C., Lo Iacono, O., Bañares, R., Abad, J., Carrión, J. A., García-Monzón, C., Caballería, J., Berenguer, M., Rodríguez-Perálvarez, M., López Miranda, J., Vilar-Gómez, E., Crespo, J., García-Cortés, M., Reig, M., Navarro, J. M., Gallego-Durán, R., Genescà, J., Arias-Loste, M. T., Pareja, M. J., Albillos, A., Muntané, J., Jorquera, F., Solà, E., Hernández-Guerra, M., Rojo, M. �. �., Salmerón, J., Caballería, L., Diago, M., Molina, E., Bataller, R., & Romero-Gómez, M. (2018). Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterologia y hepatologia, 41(7), 475-476. https://doi.org/10.1016/j.gastrohep.2018.05.011
Aller, Rocío, et al. "Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]." Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterologia y hepatologia vol. 41,7 (2018): 475-476. doi: https://doi.org/10.1016/j.gastrohep.2018.05.011
Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]. Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]. Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011. Spanish. PMID: 29929828.
Copy Download .nbib Format: NLM
Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation.

Cancers

Amado V, González-Rubio S, Zamora J, Alejandre R, Espejo-Cruz ML, Linares C, Sánchez-Frías M, García-Jurado G, Montero JL, Ciria R, Rodríguez-Perálvarez M, Ferrín G, De la Mata M.
PMID: 34069569
Cancers (Basel). 2021 May 19;13(10). doi: 10.3390/cancers13102476.

BACKGROUND: In patients with hepatocellular carcinoma (HCC), a complete clearance of circulating tumor cells (CTCs) early after liver transplantation (LT) or surgical resection (LR) could prevent tumor recurrence.METHODS: prospective pilot study including patients with HCC who underwent LR or...

Cite
Amado V, González-Rubio S, Zamora J, et al. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers (Basel). 2021;13(10)doi: 10.3390/cancers13102476.
Amado, V., González-Rubio, S., Zamora, J., Alejandre, R., Espejo-Cruz, M. L., Linares, C., Sánchez-Frías, M., García-Jurado, G., Montero, J. L., Ciria, R., Rodríguez-Perálvarez, M., Ferrín, G., & De la Mata, M. (2021). Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers, 13(10), . https://doi.org/10.3390/cancers13102476
Amado, Víctor, et al. "Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation." Cancers vol. 13,10 (2021). doi: https://doi.org/10.3390/cancers13102476
Amado V, González-Rubio S, Zamora J, Alejandre R, Espejo-Cruz ML, Linares C, Sánchez-Frías M, García-Jurado G, Montero JL, Ciria R, Rodríguez-Perálvarez M, Ferrín G, De la Mata M. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers (Basel). 2021 May 19;13(10). doi: 10.3390/cancers13102476. PMID: 34069569; PMCID: PMC8160727.
Copy Download .nbib Format: NLM
The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.

ERJ open research

Arenas-De Larriva M, Martín-DeLeon R, Urrutia Royo B, Fernández-Navamuel I, Gimenez Velando A, Nuñez García L, Centeno Clemente C, Andreo García F, Rafecas Codern A, Fernández-Arias C, Pajares Ruiz V, Torrego Fernández A, Rajas O, Iturricastillo G, Garcia Lujan R, Comeche Casanova L, Sánchez-Font A, Aguilar-Colindres R, Larrosa-Barrero R, García García R, Cordovilla R, Núñez-Ares A, Briones-Gómez A, Cases Viedma E, Franco J, Cosano Povedano J, Rodríguez-Perálvarez ML, Cebrian Gallardo JJ, Nuñez Delgado M, Pavón-Masa M, Valdivia Salas MDM, Flandes J.
PMID: 34258257
ERJ Open Res. 2021 Jul 12;7(3). doi: 10.1183/23120541.00165-2021. eCollection 2021 Jul.

BACKGROUND: The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate.PATIENTS AND METHODS: This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or...

Cite
Arenas-De Larriva M, Martín-DeLeon R, Urrutia Royo B, et al. The role of bronchoscopy in patients with SARS-CoV-2 pneumonia. ERJ Open Res. 2021;7(3)doi: 10.1183/23120541.00165-2021.
Arenas-De Larriva, M., Martín-DeLeon, R., Urrutia Royo, B., Fernández-Navamuel, I., Gimenez Velando, A., Nuñez García, L., Centeno Clemente, C., Andreo García, F., Rafecas Codern, A., Fernández-Arias, C., Pajares Ruiz, V., Torrego Fernández, A., Rajas, O., Iturricastillo, G., Garcia Lujan, R., Comeche Casanova, L., Sánchez-Font, A., Aguilar-Colindres, R., Larrosa-Barrero, R., García García, R., Cordovilla, R., Núñez-Ares, A., Briones-Gómez, A., Cases Viedma, E., Franco, J., Cosano Povedano, J., Rodríguez-Perálvarez, M. L., Cebrian Gallardo, J. J., Nuñez Delgado, M., Pavón-Masa, M., Valdivia Salas, M. D. M., & Flandes, J. (2021). The role of bronchoscopy in patients with SARS-CoV-2 pneumonia. ERJ open research, 7(3), . https://doi.org/10.1183/23120541.00165-2021
Arenas-De Larriva, Marisol, et al. "The role of bronchoscopy in patients with SARS-CoV-2 pneumonia." ERJ open research vol. 7,3 (2021). doi: https://doi.org/10.1183/23120541.00165-2021
Arenas-De Larriva M, Martín-DeLeon R, Urrutia Royo B, Fernández-Navamuel I, Gimenez Velando A, Nuñez García L, Centeno Clemente C, Andreo García F, Rafecas Codern A, Fernández-Arias C, Pajares Ruiz V, Torrego Fernández A, Rajas O, Iturricastillo G, Garcia Lujan R, Comeche Casanova L, Sánchez-Font A, Aguilar-Colindres R, Larrosa-Barrero R, García García R, Cordovilla R, Núñez-Ares A, Briones-Gómez A, Cases Viedma E, Franco J, Cosano Povedano J, Rodríguez-Perálvarez ML, Cebrian Gallardo JJ, Nuñez Delgado M, Pavón-Masa M, Valdivia Salas MDM, Flandes J. The role of bronchoscopy in patients with SARS-CoV-2 pneumonia. ERJ Open Res. 2021 Jul 12;7(3). doi: 10.1183/23120541.00165-2021. eCollection 2021 Jul. PMID: 34258257; PMCID: PMC8183029.
Copy Download .nbib Format: NLM
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference.

Transplantation

Colmenero J, Tabrizian P, Bhangui P, Pinato DJ, Rodríguez-Perálvarez ML, Sapisochin G, Bhoori S, Pascual S, Senzolo M, Al-Adra D, Herrero JI, Petrowsky H, Dawson LA, Hosni A, Kutzke JL, Gastaca M, Watt KD.
PMID: 34905760
Transplantation. 2022 Jan 01;106(1):e30-e45. doi: 10.1097/TP.0000000000003998.

De novo malignancies (DNMs) following liver transplantation (LT) have been reported as 1 of the major causes of late mortality, being the most common cause of death in the second decade after LT. The overall incidence of DNMs is...

Cite
Colmenero J, Tabrizian P, Bhangui P, et al. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference. Transplantation. 2022;106(1):e30-e45doi: 10.1097/TP.0000000000003998.
Colmenero, J., Tabrizian, P., Bhangui, P., Pinato, D. J., Rodríguez-Perálvarez, M. L., Sapisochin, G., Bhoori, S., Pascual, S., Senzolo, M., Al-Adra, D., Herrero, J. I., Petrowsky, H., Dawson, L. A., Hosni, A., Kutzke, J. L., Gastaca, M., & Watt, K. D. (2022). De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference. Transplantation, 106(1), e30-e45. https://doi.org/10.1097/TP.0000000000003998
Colmenero, Jordi, et al. "De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference." Transplantation vol. 106,1 (2022): e30-e45. doi: https://doi.org/10.1097/TP.0000000000003998
Colmenero J, Tabrizian P, Bhangui P, Pinato DJ, Rodríguez-Perálvarez ML, Sapisochin G, Bhoori S, Pascual S, Senzolo M, Al-Adra D, Herrero JI, Petrowsky H, Dawson LA, Hosni A, Kutzke JL, Gastaca M, Watt KD. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference. Transplantation. 2022 Jan 01;106(1):e30-e45. doi: 10.1097/TP.0000000000003998. PMID: 34905760.
Copy Download .nbib Format: NLM
Controlling Diabetes After Liver Transplantation: Room for Improvement.

Transplantation

Alvarez-Sotomayor D, Satorres C, Rodríguez-Medina B, Herrero I, de la Mata M, Serrano T, Rodríguez-Perálvarez M, DʼAvola D, Lorente S, Rubín A, Berenguer M.
PMID: 27653229
Transplantation. 2016 Oct;100(10):e66-e73. doi: 10.1097/TP.0000000000001399.

BACKGROUND: Diabetes mellitus is a chronic illness with great impact on long-term outcome after liver transplantation (LT). Despite this, the current level of glycemic control and quality of screening strategies for diabetes-associated conditions that are being provided to liver...

Cite
Alvarez-Sotomayor D, Satorres C, Rodríguez-Medina B, et al. Controlling Diabetes After Liver Transplantation: Room for Improvement. Transplantation. 2016;100(10):e66-e73doi: 10.1097/TP.0000000000001399.
Alvarez-Sotomayor, D., Satorres, C., Rodríguez-Medina, B., Herrero, I., de la Mata, M., Serrano, T., Rodríguez-Perálvarez, M., DʼAvola, D., Lorente, S., Rubín, A., & Berenguer, M. (2016). Controlling Diabetes After Liver Transplantation: Room for Improvement. Transplantation, 100(10), e66-e73. https://doi.org/10.1097/TP.0000000000001399
Alvarez-Sotomayor, Diego, et al. "Controlling Diabetes After Liver Transplantation: Room for Improvement." Transplantation vol. 100,10 (2016): e66-e73. doi: https://doi.org/10.1097/TP.0000000000001399
Alvarez-Sotomayor D, Satorres C, Rodríguez-Medina B, Herrero I, de la Mata M, Serrano T, Rodríguez-Perálvarez M, DʼAvola D, Lorente S, Rubín A, Berenguer M. Controlling Diabetes After Liver Transplantation: Room for Improvement. Transplantation. 2016 Oct;100(10):e66-e73. doi: 10.1097/TP.0000000000001399. PMID: 27653229.
Copy Download .nbib Format: NLM
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

Hepatic medicine : evidence and research

Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M.
PMID: 25926760
Hepat Med. 2015 Apr 13;7:1-10. doi: 10.2147/HMER.S50161. eCollection 2015.

Because of the high prevalence and associated-mortality of hepatocellular carcinoma (HCC), early diagnosis of the disease is vital for patient survival. In this regard, tumor size is one of the two main prognostic factors for surgical resection, which constitutes...

Cite
Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, et al. Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med. 2015;7:1-10doi: 10.2147/HMER.S50161.
Ferrín, G., Aguilar-Melero, P., Rodríguez-Perálvarez, M., Montero-Álvarez, J. L., & de la Mata, M. (2015). Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepatic medicine : evidence and research, 71-10. https://doi.org/10.2147/HMER.S50161
Ferrín, Gustavo, et al. "Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility." Hepatic medicine : evidence and research vol. 7 (2015): 1-10. doi: https://doi.org/10.2147/HMER.S50161
Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M. Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med. 2015 Apr 13;7:1-10. doi: 10.2147/HMER.S50161. eCollection 2015. PMID: 25926760; PMCID: PMC4403743.
Copy Download .nbib Format: NLM
Letter: unknown denominator and misleading conclusions in COVID-19.

Alimentary pharmacology & therapeutics

Rodríguez-Perálvarez M, Salcedo M, Pons JA, Colmenero J.
PMID: 33016543
Aliment Pharmacol Ther. 2020 Oct;52(7):1241-1242. doi: 10.1111/apt.16038.

No abstract available.

Cite
Rodríguez-Perálvarez M, Salcedo M, Pons JA, et al. Letter: unknown denominator and misleading conclusions in COVID-19. Aliment Pharmacol Ther. 2020;52(7):1241-1242doi: 10.1111/apt.16038.
Rodríguez-Perálvarez, M., Salcedo, M., Pons, J. A., Colmenero, J. (2020). Letter: unknown denominator and misleading conclusions in COVID-19. Alimentary pharmacology & therapeutics, 52(7), 1241-1242. https://doi.org/10.1111/apt.16038
Rodríguez-Perálvarez, Manuel, et al. "Letter: unknown denominator and misleading conclusions in COVID-19." Alimentary pharmacology & therapeutics vol. 52,7 (2020): 1241-1242. doi: https://doi.org/10.1111/apt.16038
Rodríguez-Perálvarez M, Salcedo M, Pons JA, Colmenero J. Letter: unknown denominator and misleading conclusions in COVID-19. Aliment Pharmacol Ther. 2020 Oct;52(7):1241-1242. doi: 10.1111/apt.16038. PMID: 33016543.
Copy Download .nbib Format: NLM
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.

International journal of molecular sciences

Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J, Amado-Torres V, Alejandre R, Sánchez-Frías M, Ciria R, De la Mata M, Rodríguez-Perálvarez M, Ferrín G.
PMID: 34884878
Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313073.

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm and a major cause of cancer-related death worldwide. There is no ideal biomarker allowing early diagnosis of HCC and tumor surveillance in patients receiving therapy. Liquid biopsy, and particularly circulating...

Cite
Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J, et al. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313073.
Espejo-Cruz, M. L., González-Rubio, S., Zamora-Olaya, J., Amado-Torres, V., Alejandre, R., Sánchez-Frías, M., Ciria, R., De la Mata, M., Rodríguez-Perálvarez, M., & Ferrín, G. (2021). Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313073
Espejo-Cruz, María Lola, et al. "Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313073
Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J, Amado-Torres V, Alejandre R, Sánchez-Frías M, Ciria R, De la Mata M, Rodríguez-Perálvarez M, Ferrín G. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313073. PMID: 34884878.
Copy Download .nbib Format: NLM
Malignancy of intraductal papillary neoplasm of the bile duct.

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

Aparicio Serrano A, Gómez Pérez A, Zamora Olaya JM, Rodriguez Perálvarez ML.
PMID: 34425680
Rev Esp Enferm Dig. 2021 Aug 24; doi: 10.17235/reed.2021.8193/2021. Epub 2021 Aug 24.

The intraductal papillary neoplasm of the bile duct (IPNB) is an uncommon disease which was first included in the World Health Organization classification of neoplasms in 2010. Although some patients may be asymptomatic, symptoms include most frequently abdominal pain,...

Cite
Aparicio Serrano A, Gómez Pérez A, Zamora Olaya JM, et al. Malignancy of intraductal papillary neoplasm of the bile duct. Rev Esp Enferm Dig. 2021;doi: 10.17235/reed.2021.8193/2021.
Aparicio Serrano, A., Gómez Pérez, A., Zamora Olaya, J. M., & Rodriguez Perálvarez, M. L. (2021). Malignancy of intraductal papillary neoplasm of the bile duct. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, . https://doi.org/10.17235/reed.2021.8193/2021
Aparicio Serrano, Ana, et al. "Malignancy of intraductal papillary neoplasm of the bile duct." Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva vol. (2021). doi: https://doi.org/10.17235/reed.2021.8193/2021
Aparicio Serrano A, Gómez Pérez A, Zamora Olaya JM, Rodriguez Perálvarez ML. Malignancy of intraductal papillary neoplasm of the bile duct. Rev Esp Enferm Dig. 2021 Aug 24; doi: 10.17235/reed.2021.8193/2021. Epub 2021 Aug 24. PMID: 34425680.
Copy Download .nbib Format: NLM
Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.

Transplantation

Montalvá E, Rodríguez-Perálvarez M, Blasi A, Bonanad S, Gavín O, Hierro L, Lladó L, Llop E, Pozo-Laderas JC, Colmenero J.
PMID: 34999660
Transplantation. 2022 Jan 04; doi: 10.1097/TP.0000000000004014. Epub 2022 Jan 04.

Anticoagulation and antiplatelet therapies are increasingly used in liver transplant (LT) candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to manage posttransplant complications. The implementation of the new direct-acting oral anticoagulants and the recently developed antiplatelet...

Cite
Montalvá E, Rodríguez-Perálvarez M, Blasi A, et al. Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation. Transplantation. 2022;doi: 10.1097/TP.0000000000004014.
Montalvá, E., Rodríguez-Perálvarez, M., Blasi, A., Bonanad, S., Gavín, O., Hierro, L., Lladó, L., Llop, E., Pozo-Laderas, J. C., Colmenero, J. (2022). Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation. Transplantation, . https://doi.org/10.1097/TP.0000000000004014
Montalvá, Eva, et al. "Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation." Transplantation vol. (2022). doi: https://doi.org/10.1097/TP.0000000000004014
Montalvá E, Rodríguez-Perálvarez M, Blasi A, Bonanad S, Gavín O, Hierro L, Lladó L, Llop E, Pozo-Laderas JC, Colmenero J. Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation. Transplantation. 2022 Jan 04; doi: 10.1097/TP.0000000000004014. Epub 2022 Jan 04. PMID: 34999660.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries